The potential of nanomedicine therapies to treat neovascular disease in the retina.
about
Silver and gold nanoparticles exposure to in vitro cultured retina--studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activityNanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.The ABCs of RVO: a review of retinal venous occlusion.Administration of vitamin K does not counteract the ectopic mineralization of connective tissues in Abcc6 (-/-) mice, a model for pseudoxanthoma elasticum.Nanotechnology and nanotoxicology in retinopathy.GLUT1 activity contributes to the impairment of PEDF secretion by the RPE.Novel targets against retinal angiogenesis in diabetic retinopathy.Drug delivery techniques for treating age-related macular degeneration.Targeted radiotherapy with gold nanoparticles: current status and future perspectives.Gold nanoparticle-aided brachytherapy with vascular dose painting: estimation of dose enhancement to the tumor endothelial cell nucleus.Drug Delivery Nanoparticles: Toxicity Comparison in Retinal Pigment Epithelium and Retinal Vascular Endothelial CellsCurrent advances in the treatment of neovascular age-related macular degeneration.A Novel Nanoparticle Mediated Selective Inner Retinal Photocoagulation for Diseases of the Inner Retina.Integrin Targeting and Toxicological Assessment of Peptide-Conjugated Liposome Delivery Systems to Activated Endothelial Cells.Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression.
P2860
Q21131960-80FC4156-E766-4D28-A7C6-2E961ACE599FQ34678965-8CA4D79A-467A-46F3-B4CB-717F4740A051Q35047634-28C832CA-45ED-49F2-A59B-CE428013382EQ35215438-8D58BB00-F247-4DC0-AA28-23079D0922B9Q35600266-44761F84-248F-4239-944C-8CAE7B2ED949Q37092364-BC5F3AE6-C1CB-4AE9-847F-C6EA8E8E6E12Q38013679-AA5FFD64-90DC-450C-BFF3-4262D9B59C7EQ38161953-ADC416FB-2015-4CA9-A467-A01BAD0417ACQ38224610-21FDFE08-BB50-4B32-80FA-934978987454Q38435105-599DCB6C-074A-4042-A2A1-648EC1A0731BQ38766790-E5C26AFC-E4A4-422F-B029-7D5E50080DBFQ38902191-4458C7FB-EBA0-4AF1-83C5-B11CF0030A95Q47769027-8600AD77-8A4C-4ACE-A9C3-3C4F0E93B23BQ51130308-F6D372FE-617A-4E83-B5FD-5A129F528964Q54379435-15FDB6EC-330F-451D-802D-BED66D6EEABD
P2860
The potential of nanomedicine therapies to treat neovascular disease in the retina.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@ast
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@en
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@nl
type
label
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@ast
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@en
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@nl
prefLabel
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@ast
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@en
The potential of nanomedicine therapies to treat neovascular disease in the retina.
@nl
P2860
P356
P1476
The potential of nanomedicine therapies to treat neovascular disease in the retina
@en
P2093
Jian-Xing Ma
P2860
P356
10.1186/2040-2384-2-21
P577
2010-10-08T00:00:00Z